| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-14 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-13 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-10 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.35 | 7e-10 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-08 |